Red X iconGreen tick iconYellow tick icon
  • Barclay ML, Begg EJ, Chambers ST, Boswell DR. Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro. Antimicrob Agents Chemother 1995; 39(1), 132-6 [Abstract]
  • Barclay ML, Duffull SB, Begg EJ, Buttimore RC. Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve. Aust NZ J Med 1995; 25(3), 230-5 [Abstract]
  • Begg EJ, Barclay ML, Duffull SB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 1995; 39(6), 605-9 [Abstract]
  • Begg EJ, Barclay ML. Aminoglycosides - 50 years on. Br J Clin Pharmacol 1995; 39(6), 597-603 [Abstract]
  • Begg EJ. Regional considerations in the use of once-daily aminoglycoside regimens. Drugs Ther Perspect 1995; 6(6), [No abstract]
  • Higgs CMB, Vella-Brincat J. Withdrawal with transdermal fentanyl. J Pain Symptom Manage 1995; 10(1), 4-5 [Abstract]
  • Duffull SB, Begg EJ. Why monitor peak vancomycin concentrations? Lancet 1995 Mar 11; 345(8950), 646; author reply 646-7 [Abstract]
  • Pearce MJ, Fucile DV, Duffull SB, Begg EJ. Regular paracetamol dosing reduces narcotic requirements in treating post-operative orthopaedic pain. Aust J Hosp Pharmacy 1995; 25(1), 13-18 [Abstract]
  • Vella-Brincat J, MacLeod R. Palliative care: (5) depression, insomnia and confusion. Pharmacogenomics J 1995; 254(6843), 754-6 [No abstract]
Back to top